Medartis Holding AG (SWX:MED)
80.00
-0.40 (-0.50%)
Apr 2, 2026, 11:39 AM CET
Medartis Holding AG Company Description
Medartis Holding AG, a medical device company, engages in the development, manufacturing, and sales of implant solutions worldwide.
The company’s medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery.
It provides products for the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for upper and lower extremities, mandible, midface, orthognathic under the APTUS and MODUS names, as well as CMX services through web portal, and kerimedical products.
The company was incorporated in 1997 and is headquartered in Basel, Switzerland.
Medartis Holding AG

| Country | Switzerland |
| Founded | 1997 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 1,337 |
| CEO | Matthias Schupp |
Contact Details
Address: Hochbergerstrasse 60E Basel, 4057 Switzerland | |
| Phone | 41 61 633 34 34 |
| Website | medartis.com |
Stock Details
| Ticker Symbol | MED |
| Exchange | SIX Swiss Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CHF |
| ISIN Number | CH0386200239 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Matthias Schupp | Chief Executive Officer and Member of the Executive Management Board |
| Dr. Thomas Straumann | Founder and Vice Chairman |
| Dr. Peter Hackel Ph.D. | Chief Financial Officer and Member of Executive Management Board |
| Mareike Loch | President of EMEA and Member of Executive Management Board |
| Mario Della Casa | Chief Operating Officer and Member of Management Board |
| David Thoni | President of US and Member of Executive Management Board |
| Caroline Knoeri | Chief Human Resources Officer and Executive Management Board Member |
| Marc Ammann | Executive Vice President of Research & Development and Innovation and Member of the Executive Management Board |
| Dr. Dirk W. Kirsten Ph.D. | Executive Officer |
| Anisha Wharton | Head of Regulatory Affairs |